A Study of MACI in Patients Aged 10 to 17 Years With Symptomatic Chondral or Osteochondral Defects of the Knee

Part of paid clinical trials in Palo Alto, California.

Sponsor
Vericel Corporation
Study ID
NCT03588975
Phase
PHASE3
Status
Recruiting
Apply to this trial

Conditions

  • Articular Cartilage Defect
  • Articular Cartilage Disorder of Knee
  • Chondral Defect
  • Osteochondritis Dissecans (OCD)

Eligibility Criteria

Sex
ALL
Age
10 Years - 17 Years
Healthy Volunteers
Not accepted

Interventions

  • MACI — BIOLOGICAL
    autologous cultured chondrocytes on porcine collagen membrane
  • microfracture — PROCEDURE
    Arthroscopic microfracture treatment

Study Details

The objective of this study is to compare the efficacy and safety of MACI® vs arthroscopic microfracture in the treatment of participants aged 10 to 17 years with symptomatic articular chondral or osteochondral defects of the knee.

Key Dates

First listed
Jul 17, 2018
Start date
Oct 24, 2018
Status verified
Sep 2026
Primary completion
Feb 28, 2030
Completion
Feb 28, 2030

Study Design

Enrollment
45 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: MACI
    autologous cultured chondrocytes on porcine collagen membrane
  • Other: microfracture
    surgical procedure

Primary Outcome Measure

Proportion of Participants Who Achieve ≥ 10-point Improvement From Baseline in KOOS-Child Pain and Function (Sports and Recreational Activities) Subscale Scores [ Time Frame: Baseline and Week 104 ]

Central Contacts

Locations (14)

FacilityCityStateZIPSite coordinators
Stanford University School of MedicinePalo AltoCalifornia94304
Amishi Jobanputra
[email protected]
650-498-4180
Kevin Shea (PRINCIPAL_INVESTIGATOR)
Shriners Hospital for Children Northern CaliforniaSacramentoCalifornia95817
Kory Bettencourt
[email protected]
916-453-5030
Brian Haus (PRINCIPAL_INVESTIGATOR)
University of California Davis HealthSacramentoCalifornia95817-
Ochsner Sports Medicine InstituteNew OrleansLouisiana70121-
Johns Hopkins Outpatient CenterBaltimoreMaryland21224-
University of Michigan Medsport Orthopaedic SurgeryAnn ArborMichigan48106
Christopher Ray
[email protected]
734-615-0934
Eileen Crawford (PRINCIPAL_INVESTIGATOR)
Montefiore Medical Center/Albert Einstein College of MedicineThe BronxNew York10467-
Akron Children's HospitalAkronOhio44308
John Polousky, MD
[email protected]
330-543-3500
John Polousky (PRINCIPAL_INVESTIGATOR)
The Ohio State University Jameson Crane Sports Medicine InstituteColumbusOhio43202
Jenna DeFranco
[email protected]
614-293-2761
Christopher Kaeding (PRINCIPAL_INVESTIGATOR)
Penn Medicine University CityPhiladelphiaPennsylvania19104
Dorothy Brill
[email protected]
215-273-5062
James Carey (PRINCIPAL_INVESTIGATOR)
The Children's Hospital of Philadelphia - The Hub for Clinical CollaborationPhiladelphiaPennsylvania19104
Divya Talwar
[email protected]
215-590-1527
Theodore Ganley (PRINCIPAL_INVESTIGATOR)
Texas' Children HospitalHoustonTexas77094-
Children's Medical Center PlanoPlanoTexas75024-
Children's Hospital of WisconsinMilwaukeeWisconsin53201
John Erickson, DO
[email protected]
414-337-7325
John Erickson (PRINCIPAL_INVESTIGATOR)

Find similar trials in Palo Alto, CA

By research site
Stanford University School of Medicine· Palo Alto, CAShriners Hospital for Children Northern California· Sacramento, CAUniversity of California Davis Health· Sacramento, CAOchsner Sports Medicine Institute· New Orleans, LAJohns Hopkins Outpatient Center· Baltimore, MDUniversity of Michigan Medsport Orthopaedic Surgery· Ann Arbor, MI

Related Studies